This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Wallace, K. Articles by Karagas, M. R. Search for Related Content PubMed PubMed Citation Articles by Wallace, K. Articles by Karagas, M. R.

Prediagnostic Serum Selenium Concentration and the Risk of Recurrent Colorectal Adenoma

A Nested Case-Control Study¹

Departments of Medicine [E. R. G., J. A. B.] and Community and Family Medicine [K. W., B. F. C., E. R. G., J. A. B., M. R. K.], Dartmouth Medical School, Lebanon, New Hampshire 03756; Department of Preventative Medicine and Biometrics, University of Colorado School of Medicine, Denver, Colorado 80262 [T. B.]; and Research Reactor Center, University of Missouri-Columbia, Columbia, Missouri 65211 [J. S. M., A. G., V. S.]

Several studies have suggested that selenium may help to prevent colorectal neoplasia. To investigate the relation between prediagnostic serum selenium concentrations and colorectal adenomas, we conducted a nested case-control study using data from a large, multicenter, adenoma prevention trial. Cases comprised a total of 276 patients who developed a colorectal adenoma between the year 1 and year 4 follow-up exam. Controls were 276 patients who did not develop an adenoma during this time interval, matched to case subjects on age, sex, and clinical center. Total and bound selenium concentrations were measured from baseline or year 1 serum samples using instrumental neutron activation analysis. We estimated the odds ratios of colorectal adenoma in relation to serum selenium concentrations adjusting for age, clinical center, and sex. Compared with the lowest quintile, the odds ratio for the highest quintile was 0.76 (95% confidence interval, 0.44–1.30) for total selenium and 0.60 (95% confidence interval, 0.34–1.05) for bound selenium, and there was no apparent trend in risk (P for trend = 0.50 for total selenium and P for trend = 0.20 for bound selenium). Thus, our findings do not indicate a clear association between serum selenium concentrations and adenoma recurrence.

This article has been cited by other articles:

				A. Connelly-Frost, C. Poole, J. A. Satia, L. L. Kupper, R. C. Millikan, and R. S. Sandler Selenium, apoptosis, and colorectal adenomas. Cancer Epidemiol. Biomarkers Prev., March 1, 2006; 15(3): 486 - 493. [Abstract] [Full Text] [PDF]

				U. Peters, N. Chatterjee, T. R. Church, C. Mayo, S. Sturup, C. B. Foster, A. Schatzkin, and R. B. Hayes High serum selenium and reduced risk of advanced colorectal adenoma in a colorectal cancer early detection program. Cancer Epidemiol. Biomarkers Prev., February 1, 2006; 15(2): 315 - 320. [Abstract] [Full Text] [PDF]

				E. T. Jacobs, R. Jiang, D. S. Alberts, E. R. Greenberg, E. W. Gunter, M. R. Karagas, E. Lanza, L. Ratnasinghe, M. E. Reid, A. Schatzkin, et al. Selenium and Colorectal Adenoma: Results of a Pooled Analysis J Natl Cancer Inst, November 17, 2004; 96(22): 1669 - 1675. [Abstract] [Full Text] [PDF]